Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Invitro InternationalIVRO +1.33% Gross Margin % is 81.16% as of Mar. 2026, which is 40% above its 10-year median of 57.89. The stock has 1 warning sign investors should review. Among 194 Medical Diagnostics & Research companies, Invitro International ranks better than 87.63% on this metric.
IVRO's Gross Margin % is ranked better than 87.63% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 51.445
vs IVRO: 81.88
Invitro International had a gross margin of 81.16% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Invitro International was 9.50% per year.
Invitro International (OTCPK:IVRO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Invitro International had a gross margin of 81.16% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Invitro International Gross Margin % Related Terms
Invitro International Gross Margin % Historical Data
* Premium members only.
The historical data trend for Invitro International's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVRO vs IDTA, PRPH, NSTM: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Invitro International's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invitro International Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Invitro International's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Invitro International (IVRO) has a Gross Margin % of 81.16% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Invitro International and its competitors. This is 40% above median its historical median of 57.89. Over the past decade, Invitro International's Gross Margin % has ranged from 45.45 to 81.88. According to the industry distribution chart, Invitro International ranks #24 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 12.4%.
Is Invitro International's Gross Margin % too high?
Invitro International's current Gross Margin % of 81.16% is 40% above median its 10-year median of 57.89. Over the past 10 years, this metric has ranged from a low of 45.45 to a high of 81.88. The Medical Diagnostics & Research industry median Gross Margin % is 51.45. Invitro International's value of 81.16% is 57.8% above this industry median. Based on the distribution chart, Invitro International ranks #24 out of 194 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Invitro International's Gross Margin % compare to IDTA and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, Invitro International ranks #24 out of 194 companies for Gross Margin %. This places Invitro International in the top 12% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 51.45. Invitro International's value of 81.16% is 57.8% above this benchmark. Historically, Invitro International's own Gross Margin % has ranged from 45.45 to 81.88 over the past decade. While the company's 10-year median is 57.89 vs. the industry median of 51.45, Invitro International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 51.45, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Invitro International's current Gross Margin % of 81.16% is 57.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Invitro International and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 51.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Invitro International's current Gross Margin % is 81.16%, which is 40% above median its own 10-year median of 57.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invitro International stock overvalued right now?
Based on GuruFocus' analysis, Invitro International (IVRO) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.05, compared to a current price of $0.07 — trading 35.8% above its estimated fair value. The current Gross Margin % is 81.16%, which is 40% above median its 10-year median of 57.89 and 57.8% above the Medical Diagnostics & Research industry median of 51.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Invitro International (IVRO), the current Gross Margin % is 81.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVRO has been successfully added to your 
